These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 38432603)
41. Efficacy and safety of high-dose ampicillin/sulbactam vs. colistin as monotherapy for the treatment of multidrug resistant Acinetobacter baumannii ventilator-associated pneumonia. Betrosian AP; Frantzeskaki F; Xanthaki A; Douzinas EE J Infect; 2008 Jun; 56(6):432-6. PubMed ID: 18501431 [TBL] [Abstract][Full Text] [Related]
42. Comparable Efficacy of Tigecycline versus Colistin Therapy for Multidrug-Resistant and Extensively Drug-Resistant Acinetobacter baumannii Pneumonia in Critically Ill Patients. Kim WY; Moon JY; Huh JW; Choi SH; Lim CM; Koh Y; Chong YP; Hong SB PLoS One; 2016; 11(3):e0150642. PubMed ID: 26934182 [TBL] [Abstract][Full Text] [Related]
43. Trend of extensively drug-resistant Acinetobacter baumannii and the remaining therapeutic options: a multicenter study in Tehran, Iran over a 3-year period. Jasemi S; Douraghi M; Adibhesami H; Zeraati H; Rahbar M; Boroumand MA; Aliramezani A; Ghourchian S; Mohammadzadeh M Lett Appl Microbiol; 2016 Dec; 63(6):466-472. PubMed ID: 27626896 [TBL] [Abstract][Full Text] [Related]
44. [Carbapenem restriction reduce the incidence of multidrug-resistant Acinetobacter baumannii in ventilator associated pneumonia]. Xue XS; Wang B; Deng LJ; Kang Y Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2009 Apr; 21(4):234-6. PubMed ID: 19374793 [TBL] [Abstract][Full Text] [Related]
45. Tigecycline treatment in an infant with extensively drug-resistant Acinetobacter baumannii bacteremia. Zeng J; Zhang L; Gao M; Wu J; Wu H; Chen J; Chen X; Tang W Int J Infect Dis; 2017 Aug; 61():23-26. PubMed ID: 28572073 [TBL] [Abstract][Full Text] [Related]
46. In Vitro Interactions of Antibiotic Combinations of Colistin, Tigecycline, and Doripenem Against Extensively Drug-Resistant and Multidrug-Resistant Acinetobacter baumannii. Park GC; Choi JA; Jang SJ; Jeong SH; Kim CM; Choi IS; Kang SH; Park G; Moon DS Ann Lab Med; 2016 Mar; 36(2):124-30. PubMed ID: 26709259 [TBL] [Abstract][Full Text] [Related]
47. Nosocomial Acinetobacter pneumonia: Treatment and prognostic factors in 356 cases. Özvatan T; Akalın H; Sınırtaş M; Ocakoğlu G; Yılmaz E; Heper Y; Kelebek N; İşçimen R; Kahveci F Respirology; 2016 Feb; 21(2):363-9. PubMed ID: 26635315 [TBL] [Abstract][Full Text] [Related]
48. Successful treatment of septic shock due to pan-resistant Acinetobacter baumannii using combined antimicrobial therapy including tigecycline. Taccone FS; Rodriguez-Villalobos H; De Backer D; De Moor V; Deviere J; Vincent JL; Jacobs F Eur J Clin Microbiol Infect Dis; 2006 Apr; 25(4):257-60. PubMed ID: 16572310 [TBL] [Abstract][Full Text] [Related]
49. Pharmacokinetic considerations regarding tigecycline for multidrug-resistant (MDR) Klebsiella pneumoniae or MDR Acinetobacter baumannii urosepsis. Cunha BA J Clin Microbiol; 2009 May; 47(5):1613. PubMed ID: 19403778 [No Abstract] [Full Text] [Related]
51. Ventilator-associated pneumonia due to extensive drug-resistant Acinetobacter baumannii: risk factors, clinical features, and outcomes. Özgür ES; Horasan ES; Karaca K; Ersöz G; Naycı Atış S; Kaya A Am J Infect Control; 2014 Feb; 42(2):206-8. PubMed ID: 24485378 [TBL] [Abstract][Full Text] [Related]
52. Tigecycline-based versus sulbactam-based treatment for pneumonia involving multidrug-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii complex. Ye JJ; Lin HS; Yeh CF; Wu YM; Huang PY; Yang CC; Huang CT; Lee MH BMC Infect Dis; 2016 Aug; 16():374. PubMed ID: 27496018 [TBL] [Abstract][Full Text] [Related]
53. Fluoroquinolone resistance conferred by gyrA, parC mutations, and AbaQ efflux pump among Acinetobacter baumannii clinical isolates causing ventilator-associated pneumonia. Attia NM; Elbaradei A Acta Microbiol Immunol Hung; 2019 Dec; 67(4):234-238. PubMed ID: 31833383 [TBL] [Abstract][Full Text] [Related]
54. In vivo efficacy of combination of colistin with fosfomycin or minocycline in a mouse model of multidrug-resistant Acinetobacter baumannii pneumonia. Ku NS; Lee SH; Lim YS; Choi H; Ahn JY; Jeong SJ; Shin SJ; Choi JY; Choi YH; Yeom JS; Yong D; Song YG; Kim JM Sci Rep; 2019 Nov; 9(1):17127. PubMed ID: 31748527 [TBL] [Abstract][Full Text] [Related]
55. Outcomes in patients infected with carbapenem-resistant Acinetobacter baumannii and treated with tigecycline alone or in combination therapy. Guner R; Hasanoglu I; Keske S; Kalem AK; Tasyaran MA Infection; 2011 Dec; 39(6):515-8. PubMed ID: 21789524 [TBL] [Abstract][Full Text] [Related]
56. Multidrug-resistant Acinetobacter baumannii bacteremia treated with tigecycline in two pediatric burn patients. Kanık-Yüksek S; Tezer H; Ozkaya-Parlakay A; Gulhan B; Sayed-Oskovi H; Kara A; Şenel E Pediatr Infect Dis J; 2015 Jun; 34(6):677. PubMed ID: 25970113 [No Abstract] [Full Text] [Related]
57. Late onset ventilator-associated pneumonia due to multidrug-resistant Acinetobacter spp.: experience with tigecycline. Curcio D; Fernández F; Vergara J; Vazquez W; Luna CM J Chemother; 2009 Feb; 21(1):58-62. PubMed ID: 19297274 [TBL] [Abstract][Full Text] [Related]